Motohiro Kato, MD1*, Kumi Nakazaki2*, Yasuharu Sato3*, Kengo Takeuchi, MD4*, Masashi Sanada5*, Yoshitaka Asakura6*, Satsuki Muto7*, Yuyan Chen1*, Junko Takita1*, Yasuhide Hayashi8*, Takashi Igarashi1*, Toshiki Watanabe7*, Kensei Tobinai, MD6, Yuichi Ishikawa4*, Shigeo Mori, MD9*, Mineo Kurokawa, MD, PhD2, Tadashi Yoshino, MD3*, Yukio Kobayashi6* and Seishi Ogawa, MD, PhD5
1Department of Pediatrics, The University of Tokyo, Tokyo, Japan
2Hematology and Oncology, Graduate School of Med., Tokyo, Japan
3Department of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan
4Department of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research,, Tokyo, Japan
5Cncer Genomics Project, University of Tokyo, Tokyo, Japan
6National Cancer Center Hospital, Tokyo, Japan
7The institute of Medical Science, Unviersity of Tokyo, Tokyo, Japan
8Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
9Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan